Skip to main content

Greenberg Traurig’s Emily Ladd-Kravitz and Andrew (A.J.) Tibbetts Present at HealthTech Build’s Women CEO & Founders Roundtable

BOSTON – March 21, 2025 – Emily Ladd-Kravitz, co-chair of the Venture Capital & Emerging Technology Group of global law firm Greenberg Traurig, LLP’s Boston office, and Andrew (A.J.) Tibbetts, an Intellectual Property & Technology shareholder, presented at HealthTech Build’s Women CEO & Founders Roundtable, March 12. Greenberg Traurig hosted the curated, half-day program in its Boston office. The event was open to all.

“The CEO Playbook: Skill-building & Critical Connections” brought together 20 women leaders in healthcare and life sciences for candid conversations, peer-driven insights, and actionable strategies to tackle pressing business challenges. Ladd-Kravitz moderated the panel, “Inside the Investor Mind: What You Need to Know,” and Tibbetts moderated the panel, “Why Questioning Yourself Matters: Value & Product-Market Fit.”

Ladd-Kravitz focuses her legal practice on complex corporate transactions and representation of institutional investors across a variety of industries and private companies in all stages of their life cycles. She represents venture capital funds, private equity firms, other institutional investors, and companies in connection with a wide variety of corporate and transactional matters, including venture capital financings, mergers and acquisitions, minority investments, and corporate governance matters. Ladd-Kravitz also advises startup and growth-stage companies in all industries, including technology, edtech, medical device, clean energy, sustainable solutions, and life sciences.

Tibbetts leverages prior experience as a software engineer to provide business-oriented intellectual property strategies for software, AI, and electronics-based technologies. He counsels on matters related to software-implemented tech across a range of industries, from networking, fintech, and natural language processing to life sciences, artificial intelligence, medical records, and medical devices. Tibbetts advises a wide array of clients, ranging from international and publicly traded companies and large research institutions to small and growing companies. He serves on the board of directors of MassMEDIC and HealthTech Build, helping to support digital health efforts in the New England area.